Senior Lecturer, Chief Chinese Medicine Physician, Associate Professor of Practice

Education 1983.9--1988.7: Zhejiang Chinese Medical University. Bachelor in Chinese Medicine 1990.9--1993.6: Fujian University of Chinese Medicine. MPhil in Integrative Internal Medicine 2000.9--2003.7: Zhejiang Chinese Medical University. PhD in Chinese Internal Medicine 2003.8--2005.9 School of Medicine, Zhejiang University Postdoctoral fellow in Endocrinology and Metabolism Qualifications 01/08/1989. Ningbo Yinzhou Personnel Bureau Chinese Medicine Practitioner 01/08/1994. Ningbo Personnel Bureau Physician-in-charge 01/05/1999. Department of Health of Zhejiang Province Integrative Medicine Practitioner 10/10/1999. Department of Personnel of Zhejiang Province Endocrine Associate Chief Physician，Associate Professor 09/09/2005. Chinese Medicine Council of Hong Kong Registered Chinese Medicine Practitioner 06/08/2005 The University of Hong Kong Senior Physician,Teaching Consultant 16/04/2018 Hong Kong Baptist University Senior Lecturer,Chief Physician,Associate Professor of Practice Publication list 1. Jianli Cui，Youfu Ke. Comparative Analysis of Nine COVID-19 Convalescent Plasma Protocols Registered by Cochrane Central Register of Controlled Trials. Iranian Red Crescent Medical Journal, 22(8). https://doi.org/10.32592/ircmj.2020.22.8.47 ( SCI) 2. Youfu Ke, Jianli Cui, Yunkeung Wong. Ecological Study on Differences in COVID-19 Fatality Among Wuhan, Rest of Hubei, and Rest of China. Journal of Epidemiology and Global Health.2020；DOI: https://doi.org/10.2991/jegh.k.200902.001 ( SCI) 3. Youfu Ke, Jianli Cui. Chinese Medicine Treatment of Cytokine Storm Caused by COVID-19. Iranian Red Crescent Medical Journal.2020; 22(7): e104483.DOI : 10.5812/ircmj.104483. (SCI ) 4. Ke Y, Chen Z, Peng B. Cross-Sectional Study of SARS-CoV-2 Epidemic in China and Implications for the World, Iranian Red Crescent Medical Journal.2020; 22(4): e102685. doi: 10.5812/ircmj.102685.（SCI） 5. Jianli Cui. Youfu Ke. A Review of Characteristics, Transmission, Mortality and Treatment of SARS-CoV-2. International Journal of Scientific Research.2020; 9(6): 1-2 6. Youfu Ke, Jianli Cui. Comparison of Fatality Rates of Top 201 COVID-19 Countries and Its Enlightenment on How to Fight the Pandemic Better. Global Journal For Research Analysis. 2020; 9(5):1-3. 7. Jianli Cui, Youfu Ke. A Review of COVID-19 Convalescent Plasma Clinical Trials and Protocols for SARS-CoV-2. Global Journal For Research Analysis. 2020; 9(5):1-5. 8. Youfu Ke, Zemin Chen, Bo Peng, Hoyan Wong, Yunkeung Wong, and Zhichao Yuan. Comparative analysis of COVID-19 epidemic in Hubei province and rest parts of mainland China. International Journal of Scientific Research.2020; 9(3) 扶正抑瘤法治療惡性腫瘤的用藥策略[J].中醫臨床研究,2014 《傅青主女科》應用植物雌激素治療不孕症探究[J].中醫臨床研究.2014 Essential Hypertension Treated by Wuling Powder and Modified Tianma Gouteng Decoction: a Cohort Study Without Controls.Complementary Therapies in Medicine. 2013 (SCI ) Open Add-on Study on Primary Hypertension Treated by Wuling Powder and Modified Tianma Gouteng Decoction. Clinical Study on Wuling Powder and Modified Shengmai Powder Treating Chronic Cardiac Insufficiency. 益氣養陰化瘀法治療糖尿病腎病的用藥策略 植物雌激素防治圍絕經期綜合征 植物雌激素防治激素依賴性腫瘤研究進展 魔芋葡甘聚糖治疗代谢综合征的临床研究 魔芋葡甘露聚糖治疗2型糖尿病初步临床观察. 魔芋葡甘露聚糖减肥降压的初步临床观察. 魔芋葡甘露聚糖减肥降脂的初步临床观察. 魔芋葡甘聚糖防治代谢综合征开发前景. 代謝綜合征中醫藥防治. 慢性心功能不全的中醫藥防治. 《咳嗽的診斷與治療指南》對中醫治療咳嗽的啟示. 中醫藥防治腎性高血壓. 國家科技進步二等獎藥物生血寧片藥效與安全再評價. 中醫藥治療卵巢功能不全. 中醫藥防治糖尿病合併高血壓. 手足口病中醫藥診治策略 生血寧治療缺鐵性貧血的臨床研究 生血寧治療失血性貧血及調節鐵代謝相關基因的實驗研究． 鐵代謝與缺鐵性貧血研究進展. 生血寧對缺鐵性與失血性貧血造血功能的影響. 蠶砂提取物研製中藥Ⅱ類新藥生血寧. 生血寧對缺鐵性貧血患者氣血兩虛證的影響 生血寧片對缺鐵性貧血鐵代謝分子指標的影響 二甲雙胍對胰島素抵抗患者血脂和胰島素敏感性的影響 The effect of metformin on insulin resistance of type 2 diabetic patients complicated with essential hypertension. 《傷寒論》辨治原則探討． 藥物穴位封閉治療産後尿瀦留21例臨床觀察. 納絡酮治療急性酒精中毒的臨床觀察. 永久心臟起搏若干問題探討. Ⅱ型糖尿病合幷高血壓患者胰島素抵抗的研究 經皮球囊導管左房室瓣成形術（附24例報告） 礦泉851口服液R型和Y型延緩衰老的臨床研究. 334例TSH－IRMA异常者T3,T4與FT3,FT4測定的對比研究. 慢性阻塞性肺病和肺心病時血漿心鈉素與內皮素的測定. 充血性心力衰竭患者心鈉素內皮素與內源性洋地黃樣物質的變化. 糖尿病血管幷發症中西醫易患因素綜述.